Noguchi N, Tamura Y, Katayama J, Narui K
Department of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Japan.
FEMS Microbiol Lett. 1998 Feb 15;159(2):337-42. doi: 10.1111/j.1574-6968.1998.tb12880.x.
The genes mphA and mphB encode macrolide 2'-phosphotransferases I and II, respectively, and they confer resistance to macrolide antibiotics in Escherichia coli. To study the expression of these genes in Gram-positive bacteria, we constructed recombinant plasmids that consisted of an mph gene and the pUB110 vector in Bacillus subtilis. When these plasmids were introduced into Staphylococcus aureus, the mphB gene was active and macrolide 2'-phosphotransferase II was produced. The gene endowed S. aureus with high-level resistance to spiramycin, a macrolide antibiotic with a 16-membered ring. Moreover, transcription of the mphB gene in S. aureus began at the promoter that was active in E. coli.